It’s been a busy week in Australian pharmacy…
Pharmacy Guild Executive Director David Quilty wrote this week about how the Guild and its analysts have identified nine key ways forward… and said that pharmacy needs to take action now.
The ABC’s Gruen took a look at what makes Chemist Warehouse tick, Sigma Healthcare announced their results and discussed some challenges including exclusive direct supply, and the Government announced a review into the CSO, which will include exclusive supply arrangements among others.
PSA National President Shane Jackson and Vice President Chris Freeman discussed the benefits of having pharmacists in GP surgeries, while the Guild’s Anthony Tassone wondered if other priorities shouldn’t be tackled first.
NSW pharmacy leaders slammed NSW decision makers regarding the tardiness of their approach to real-time monitoring. And the Guild wants some details about the e-script initiative announced in the Budget.
In the world of opioids, we looked at an initiative that aims to improve prescribing on hospital discharge; how SHPA plans to use survey results to target opioid-related harms; and how Pharmacy 777 and ScriptWise are encouraging pharmacists to start conversations about opioids, and benzodiazepines as well.
And the Turnbull Government announced the opt-out period for My Health Record as well as touching on some privacy concerns… but Labor’s Catherine King wasn’t impressed, saying the Government has a “woeful” track record on IT privacy and security.
The Guild also came under fire, with the union calling it a “disgrace” over its position on wages; as did the PSA for its training deal with Chemist Warehouse, with Georgina Twomey, President of the Australian College of Pharmacy, saying PSA underestimated the backlash.